Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5524724 | Blood Reviews | 2016 | 11 Pages |
Abstract
Radioimmunotherapy is increasingly used alone and in combination with standard chemotherapy as a preparative conditioning tool for patients with variety of hematological malignancies before allogeneic and autologous stem cell transplantation. This approach, if optimized, has the potential to close the gap between the benefit and toxicity of conditioning regimens. This article is intended to provide a summary of the basic elements of this approach as well as a concise and up-to-date scoping review of the studies that evaluated the safety and efficacy of integrating radioimmunotherapy in the conditioning regimens.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alaa M. Ali, Farrokh Dehdashti, John F. DiPersio, Amanda F. Cashen,